Skip to main
AHCO

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth is expected to continue its strong organic growth and cross-selling opportunities through its expanded offering of products and services. With a scalable platform and low-cost infrastructure, the company is well-positioned for strong operating leverage and margin expansion. While there are potential risks, such as reimbursement pressure and regulatory issues, there is a strong upside potential for AdaptHealth's stock as it continues to expand and solidify its position in the home healthcare market.

Bears say

AdaptHealth is a market leader in the home medical equipment industry, driven by an innovative and efficient operating model and first-mover advantages. However, potential challenges such as supply chain disruptions from the recent Philips recall and regulatory changes in fee schedules and Medicare reimbursements could negatively impact its earnings. Additionally, the company's heavy reliance on the Sleep Health segment for majority of its revenues poses a risk if there is a slowdown in demand for sleep therapy equipment and services.

AdaptHealth Corp (AHCO) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 5 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.